Citations

Mayo Clinic

Showing 10 of 108453 citations.

OT04 | GOLSEEK‐1: A PHASE 3, DOUBLE‐BLIND, RANDOMIZED STUDY OF GOLCADOMIDE + R‐CHOP VERSUS PLACEBO + R‐CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK, LARGE B‐CELL LYMPHOMA
Nowakowski, Grzegorz S. , Bouzani, Maria, Kwiatek, M., Berkovits, Alejandro, Gkasiamis, Argyrios, Patel, Amar , Boucaud, Floriane, Petel, Adrien , Hoffmann, Marc Steven , Muñoz, Javier , Westin, Jason R. , Jurczak, Wojciech , Huang, Tien‐Shang , Klingbiel, Dirk , Vassilakopoulos, Theodoros P.

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70093_ot04 Get It

271 | LEUKEMIC NON‐NODAL MANTLE CELL LYMPHOMA IS NOT NECESSARILY EQUIVALENT TO INDOLENT MCL: A REPORT FROM THE LEO COHORT STUDY
Zhuang, Tony , Pongas, Georgio, Watkins, Mary P., Yu, Ning , Reagan, P. M., Riska, Shaun M., Lossos, Izidore S. , Wang, Y., Flowers, Christopher R. , Martin, Peter , Cohen, Jonathon B. , Chen, Yihua , Switchenko, Jeffrey M. , Atallah‐Yunes, Suheil Albert , Yu, N., Jaye, David L. , Vij, Kiran R , Feldman, Andrew L. , Larson, Melissa C. , Farooq, Umar , Kahl, Brad S. , Cerhan, James R. , Martin, P.

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70094_271 Get It

175 | CYCLIN D1 OVEREXPRESSION INDUCES REPLICATION STRESS AND MICROHOMOLOGY‐MEDIATED END‐JOINING DEPENDENCE FOR DNA DAMAGE REPAIR IN MANTLE CELL LYMPHOMA
Abeykoon, Jithma P. , Hirohashi, Yoshihiko , Moreau, Lisa A. , Iyer, Deepak , Mukkavalli, Sirisha , Parmar, Kalindi , Zambrano, Gerardo , Jiang, L., Dai, Yi , Gwin, Kimberly, King, R., Wu, Xiaosheng , Asada, Shuhei , Zhu, G., Iyer, D., Zambrano, G., Jiang, L., Yi, D., Manske, Michelle K. , Lou, Zhenkun , Shapiro, Geoffrey I. , Witzig, Thomas E. , D’Andrea, Alan D.

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70094_175 Get It

Sprains, Strains and Growing Pains: Managing Cognitive Bias to Facilitate Timely Diagnosis in Pediatric Sports Medicine
Scott, Parker, Sim, Leslie , Soma, David , Madsen, Bo E., Thorsteinsdottir, Bjorg , Thorsteinsdottir, Bjoerg , Sim, Leslie A

Children | June 16, 2025 | Volume: 12 | Issue: 6 | Pages: 784

10.3390/children12060784 | PMID 40564742 Get It

Background: Diagnostic delay and error represent pervasive problems in healthcare with grave implications for treatment and prognosis. Though characteristic of human cognition, cognitive biases commonly contribute to delays in the physician decision-making process, particularly in atypical or complex presentations in youth. Methods: We present a case series of three adolescent athletes with varied clinical presentations whose diagnostic conceptualization and treatment were delayed in part due to cognitive biases with consequences for overall health and development, as well as return to sport. Results: The first case depicts how an atypical presentation of celiac disease was attributed to growing pains, illustrating the contribution of anchoring bias and confirmation bias in medical decision making. The second case represents the misattribution of chronic exertional compartment syndrome pain to growing pains and post-exercise soreness, highlighting the influence of ascertainment bias on the initial misdiagnosis. The third case describes how a vertebral mass was misdiagnosed as a left shoulder strain from weightlifting, depicting the contribution of anchoring bias and ascertainment bias in medical decision making. Conclusions: Early recognition of cognitive biases, including confirmation bias, anchoring bias, and ascertainment bias, is crucial for improving medical decision making, particularly in cases of rare or atypical presentations, reducing unnecessary diagnostic delays, and setting more realistic patient expectations. Through discussion of these cases, we highlight concrete steps to manage bias to facilitate timely diagnosis within the primary care and sports medicine setting.
264 | CD3XCD20 BISPECIFIC ANTIBODIES IN TRANSFORMED WALDENSTRÖM MACROGLOBULINEMIA/LYMPHOPLASMACYTIC LYMPHOMA
Brocard, Marie-Paule, Kanagaratnam, Lukshe , Bussot, Lucile, Papoular, Benjamin, Chevreux, Steeve, Vaugeois, Tristan, Toussaint, Elise , Kapoor, Prashant , Durot, Éric , Brocard, M., Roos-Weil, Damien , Tomowiak, Cécile , Crochet, Gilles , Quinquenel, Anne

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70094_264 Get It

Developing and sustaining inclusive language in biomedical informatics communications: an AMIA Board of Directors endorsed paper on the Inclusive Language and Context Style Guidelines
Walk, Oliver Bear Don’t, Haldar, Shefali , Wei, Duo, Huang, Hu , Keloth, Vipina K. , Leung, Tiffany I. , Desai, Pooja , Korngiebel, Diane M. , Wiley, Laura K. , Ogunyemi, Omolola , Dirks, Lisa G. , Kronk, Clair , Martin, Krista, Anand, Tara V. , Volpe, Salvatore G, Yung, Nathan , Lucero, Robert , Bright, Tiffani J , Walk, Oliver J. Bear Don’t , Fan, Jungwei , Keloth, Vipina K , Desai, Pooja , Grossman Liu, Lisa , Pichon, Adrienne , Subbian, Vignesh , Solomonides, Anthony E , Wiley, Laura K , Ogunyemi, Omolola , Iott, Bradley , Kronk, Clair , Foraker, Randi , Anand, Tara , Bear Don't Walk Iv, Oliver J , Rivera, Rebecca L. , Fan, Jungwei , Subbian, Vignesh , Solomonides, Anthony , Jackson, Gretchen Purcell , Dankwa‐Mullan, Irene , Everhart, Avery , Parker, Andrea G. , Foraker, Randi E. , Volpe, Salvatore G, Rizvi, Rubina F

Journal of the American Medical Informatics Association | June 16, 2025 | Volume: 32 | Issue: 8 | Pages: 1380-1387

10.1093/jamia/ocaf096 | PMID 40523007 Get It

Abstract Objectives In 2023, AMIA’s Inclusive Language and Context Style Guidelines (the “Guidelines”) were approved by the Board of Directors and made a publicly available resource. This work began in 2021 through AMIA’s DEI Task Force and subsequent DEI Committee; many members provided input, feedback, and time to create the Guidelines. In this paper, the authors provide a transparent account of the origin, development, contents, and dissemination of the Guidelines and share plans for their future development and use. Materials and Methods Our approach to drafting, refining, and distributing the Guidelines included consulting existing language guides, AMIA member reviews, external expert reviews, webinars, and workshops. Through an iterative approach to drafting and refining the Guidelines, the authors consulted relevant language guidelines and many experts throughout and beyond the AMIA community. Results The Inclusive Language Context Guidelines were formally approved by the AMIA Board of Directors on February 15, 2023. The Guidelines included four principles to be considered in scientific communications: Plurality, Precision, Transparency, and Destigmatization. Discussion A moment of vulnerability where an AMIA member raised concerns about the use of harmful language during a presentation resulted in the creation of a principled approach to support inclusive language within biomedical and health informatics communications. We envision that the Guidelines will support health equity by challenging dominant public narratives around health, fostering stronger interdisciplinary collaboration and critical thinking about the impact of language, and creating a more welcoming environment for the broader AMIA community. This work could not have been completed without the support of many AMIA members and other researchers in biomedical and health informatics. The Guidelines are a living document that will continue to be updated with input and feedback from the AMIA community into the future.
92 | EO2463 (EO) PEPTIDE IMMUNOTHERAPY IN COMBINATION WITH LENALIDOMIDE (L) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH FOLLICULAR (FL) AND MARGINAL ZONE LYMPHOMA (MZL)
Wallace, D. S., Smith, Stephen D. , García, Carlos Grande, Marolleau, Jean Pierre, García, C. Bousoño , Rinaudo, Paolo , Chêne, Laurent , Fagerberg, Jan , Friedberg, Jonathan W. , Armand, P., Ansell, Stephen M. , Villasboas, José C. , Bosch, Francesc Xavier , Pinto, Antonio , Merryman, Reid W. , Arcaini, Luca , Gutiérrez, Norma C. , Marolleau, Jean‐Pierre, Till, Brian G. , García, C., Filippi, Rosaria De , Rinaudo, P., Fagerberg, J., Zinzani, Pier Luigi

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70093_92 Get It

A Pilot Randomized Controlled Clinical Trial to Test the Feasibility, Acceptability, and Usability of iPREPARED; A Mobile Health Technology for Patients and Care Partners
Ayala, Ivan N. , Friesen, H , Bellolio, Fernanda , Boustani, Zayn , Chambers, Stephanie, Musey, Paul I. , Boustani, Malaz, Friesen, Hannah, Bellolio, M Fernanda , Pagali, Sandeep R. , Lindroth, Heidi

Delirium | June 16, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.56392/001c.127872 | PMID 40919583 Get It

Background Family participation in the delivery of nonpharmacological measures has shown in past studies to prevent 17-75% of incident delirium. A scalable and sustainable method to partner with family (i.e., care partners) and support their delivery of nonpharmacologic measures is needed. Objectives To test the feasibility, acceptability, and usability of iPREPARED in a pilot randomized controlled clinical trial (RCT). iPREPARED is a mobile health technology co-designed with patients and care partners containing resources on nonpharmacological interventions to prevent delirium. Methods Hospitalized adults ( > 65 years) with > 1 delirium risk factor and a care partner (family or friend > 18yo) willing to participate were enrolled. The primary outcomes were feasibility, acceptability, and usability. Descriptive statistics are reported. Results In total, 23 dyads completed the study (median age 72 years (IQR 64, 79), 60% male, and 100% Caucasian). Dyads reported that iPREPARED was acceptable, with moderate usability. Recruitment in the emergency department was feasible whereas recruitment once hospitalized and admitted was more difficult. Conclusion The study design was feasible. iPREPARED was acceptable and usable as an intervention.
199 | PEMBROLIZUMAB THERAPY INDUCES AN INFLAMMATORY RESPONSE IN LYMPHOMA PATIENTS BY RESHAPING MONOCYTES RESULTING IN HYPERPROGRESSIVE DISEASE
Tang, Xinyi , Mukherjee, Pinku , Wang, Y., Ansell, Stephen M. , Yang, Zhi-Zhang , Bhardwaj, Vaishali , Mukherjee, P., Wang, Yucai , Mondello, Patrizia , Pan‐Hammarström, Qiang

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70094_199 Get It

Creating a Superiorly Based Pharyngeal Flap: Is Prominence of C1 Superior Enough, and Will Adenoid Pad Be in the Way?
Snodgrass, Taylor D. , Gilbert, Imani , Snodgrass, Taylor , Sitzman, Thomas J. , Chee-Williams, Jessica L. , Tollefson, Travis T. , Singh, Davinder , Perry, Jamie L.

Plastic and Reconstructive Surgery - Global Open | June 16, 2025 | Volume: 13 | Issue: 6 | Pages: e6797

10.1097/gox.0000000000006797 | PMID 40524880 Get It

Background: Positioning the pharyngeal flap base high along the posterior pharyngeal wall is essential for optimizing speech outcomes. Objective data on where to place the flap base are lacking. Further, adenoid tissue can restrict cephalad positioning of the flap. This study aimed to improve the design of the pharyngeal flap by measuring the distance from the first cervical vertebrae (C1) to the palatal plane, and the adenoid depth in children undergoing evaluation for velopharyngeal insufficiency. Methods: This retrospective cross-sectional study analyzed magnetic resonance imaging (MRI) scans of the velopharynx and measured the distance between C1 and the palatal plane, and the adenoid depth at the level of the palatal plane in millimeters. Results: Thirty-four patients met the inclusion criteria. The mean age at the time of MRI was 7.4 years (range: 3.9–11.9 y). The anterior tubercle of C1 was below the palatal plane in 97% (n = 33) of patients. On average, this landmark was 10.5 mm (SD = 5.0) below the palatal plane. Adenoid tissue was present at the level of the palatal plane in 91% (n = 31) of patients. Conclusions: Positioning the pharyngeal flap base at C1 is too low to aid with velopharyngeal closure. Further, adenoid tissue is frequently present at the level of velopharyngeal closure, limiting superior positioning of the pharyngeal flap base. When this occurs, surgeons should consider adenoidectomy before pharyngeal flap surgery. Preoperative MRI may be beneficial for planning pharyngeal flap positioning relative to C1 and assessing adenoid tissue at the palatal plane.